The American Journal of Bioethics· 2026Q1
Employment-Related Risks in a Clinical Trial of Psychedelic Treatment for Chronic Pain
- 5citations
- Q1SCImago
- 2026year
Short summary
Clinical trials of psychedelic treatments for chronic pain must address employment-related risks, such as potential job loss or discrimination, due to the nature of the treatment and its potential effects on cognitive and emotional states.
AI-generated from the title and abstract; the full text is not read.
Key points
- Psychedelic treatments for chronic pain may pose employment-related risks to participants.
- Risks include potential job loss, discrimination, or inability to perform job duties due to treatment effects.
- Clinical trial protocols must proactively address and mitigate these employment risks.
- Ethical and legal frameworks are needed to protect participants' employment status.
AI-generated from the title and abstract; the full text is not read.
Abstract
Chronic pain is a significant health problem affecting up to 20% of Americans (Yong et al. 2022), negatively affecting overall health and quality of life, causing disability, and burdening healthca...
The authors' abstract, as published at the source. The American Journal of Bioethics, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Clinical Psychology
Clinical PsychologyPsychology